About: BTK Inhibitor ONO-4059     Goto   Sponge   Distinct   Permalink

An Entity of Type : owl:Class, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:label
  • BTK Inhibitor ONO-4059
rdfs:subClassOf
Semantic_Type
  • Pharmacologic Substance
Preferred_Name
  • BTK Inhibitor ONO-4059
NCI_META_CUI
  • CL437179
PDQ_Open_Trial_Search_ID
  • 738477
PDQ_Closed_Trial_Search_ID
  • 738477
FULL_SYN
  • Bruton's Tyrosine Kinase Inhibitor ONO-4059SYNCI
  • ONO-4059CNNCI
  • BTK Inhibitor ONO-4059PTNCI
DEFINITION
  • An orally available formulation containing an inhibitor of Bruton agammaglobulinemia tyrosine kinase (BTK), with potential antineoplastic activity. Upon administration, ONO-4059 covalently binds to BTK within B cells, thereby preventing B cell receptor signaling and impeding B cell development. As a result, this agent may inhibit the proliferation of B cell malignancies. BTK, a cytoplasmic tyrosine kinase and member of the Tec family of kinases, plays an important role in B lymphocyte development, activation, signaling, proliferation and survival.NCI
code
  • C102876
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 116 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software